These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S. Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112 [Abstract] [Full Text] [Related]
10. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA. Leuk Res; 2008 Apr; 32(4):553-8. PubMed ID: 17888511 [Abstract] [Full Text] [Related]
12. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Kitagawa M, Kamiyama R, Kasuga T. Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317 [Abstract] [Full Text] [Related]